{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:26:01Z","timestamp":1784042761178,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:00:00Z","timestamp":1469145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13105-016-0506-4","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T05:49:23Z","timestamp":1469166563000},"page":"679-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus"],"prefix":"10.1007","volume":"72","author":[{"given":"Asuman","family":"Kurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclnur","family":"Andican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep O\u015far","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahat","family":"Andican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclden","family":"Burcak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,22]]},"reference":[{"issue":"Suppl 1","key":"506_CR1","first-page":"S61","volume":"31","author":"JP Bantle","year":"2008","unstructured":"American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl 1):S61\u201378","journal-title":"Diabetes Care"},{"issue":"5","key":"506_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MCA.0b013e3282fec058","volume":"19","author":"G Basta","year":"2008","unstructured":"Basta G, Berti S, Cocci F, Lazzerini G, Parri S, Papa A, Battaglia D, Lubrano V, Del Turco S, Ravani M, Rizza A, De Caterina R, Marraccini P, Mazzone A (2008) Plasma N-epsilon-(carboxymethyl) lysine levels are associated with the extent of vessel injury after coronary arterial stenting. Coron Artery Dis 19(5):299\u2013305","journal-title":"Coron Artery Dis"},{"key":"506_CR3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","volume":"63","author":"G Basta","year":"2004","unstructured":"Basta G, Schmidt AM, De Caterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582\u2013592","journal-title":"Cardiovasc Res"},{"issue":"8","key":"506_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/obr.12189","volume":"15","author":"N Bender","year":"2014","unstructured":"Bender N, Portmann M, Heg Z, Hofmann K, Zwahlen M, Egger M (2014) Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis. Obes Rev 15(8):657\u2013665","journal-title":"Obes Rev"},{"issue":"4","key":"506_CR5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2337\/dc06-1332","volume":"30","author":"R Caterina De","year":"2007","unstructured":"De Caterina R, Madonna R, Bertolotto A, Schmidt EB (2007) n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care 30(4):1012\u20131026","journal-title":"Diabetes Care"},{"key":"506_CR6","doi-asserted-by":"crossref","first-page":"11143","DOI":"10.1016\/S0021-9258(19)38569-2","volume":"265","author":"CJ Field","year":"1990","unstructured":"Field CJ, Ryan EA, Thomson AB, Clandinin MT (1990) Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 265:11143\u201311150","journal-title":"J Biol Chem"},{"key":"506_CR7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2337\/diacare.21.4.494","volume":"21","author":"CE Friedberg","year":"1998","unstructured":"Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE (1998) Fish oil and glycemic control in diabetes: a meta-analysis. Diabetes Care 21:494\u2013500","journal-title":"Diabetes Care"},{"issue":"4","key":"506_CR8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/193229680900300424","volume":"3","author":"KE Friedl","year":"2009","unstructured":"Friedl KE (2009) Waist circumference threshold values for type 2 diabetes risk. J Diabetes Sci Technol 3(4):761\u2013769","journal-title":"J Diabetes Sci Technol"},{"key":"506_CR9","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","volume":"271","author":"MX Fu","year":"1996","unstructured":"Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR (1996) The advanced glycation end product, N epsilon-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982\u20139986","journal-title":"J Biol Chem"},{"key":"506_CR10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-108-5-663","volume":"108","author":"H Glauber","year":"1988","unstructured":"Glauber H, Wallace P, Griver K, Brechtel G (1988) Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108:663\u2013668","journal-title":"Ann Intern Med"},{"issue":"2","key":"506_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9440(10)61723-3","volume":"159","author":"MT Goova","year":"2001","unstructured":"Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, Nowygrod S, Wolf BM, Caliste X, Yan SF, Stern DM, Schmidt AM (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159(2):513\u2013525","journal-title":"Am J Pathol"},{"key":"506_CR12","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1016\/S0021-9258(18)99006-X","volume":"266","author":"SK Grandhee","year":"1991","unstructured":"Grandhee SK, Monnier VM (1991) Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem 266:11649\u201311653","journal-title":"J Biol Chem"},{"issue":"9177","key":"506_CR13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","volume":"354","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico","year":"1999","unstructured":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354(9177):447\u2013455","journal-title":"Lancet"},{"key":"506_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.33549\/physiolres.930744","volume":"55","author":"MM Haluzik","year":"2006","unstructured":"Haluzik MM, Haluzik M (2006) PPAR-alpha and insulin sensitivity. Physiol Res 55:115\u2013122","journal-title":"Physiol Res"},{"issue":"Suppl:S","key":"506_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02562312","volume":"34","author":"WS Harris","year":"1999","unstructured":"Harris WS (1999) n-3 fatty acids and human lipoprotein metabolism: an update. Lipids 34(Suppl:S):257\u2013258","journal-title":"Lipids"},{"issue":"5","key":"506_CR16","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1096\/fj.07-9909com","volume":"22","author":"BI Hudson","year":"2008","unstructured":"Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, Grant PJ, Schmidt AM (2008) Identification, classification, and expression of RAGE gene splice variants. FASEB J 22(5):1572\u20131580","journal-title":"FASEB J"},{"key":"506_CR17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3132\/dvdr.2008.031","volume":"5","author":"N Katakami","year":"2008","unstructured":"Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Yasuda T, Sakamoto K, Yamasaki Y (2008) Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients. Diab Vasc Dis Res 5:190\u2013197","journal-title":"Diab Vasc Dis Res"},{"issue":"4","key":"506_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S0029665109990231","volume":"68","author":"J Kopecky","year":"2009","unstructured":"Kopecky J, Rossmeisl M, Flachs P, Kuda O, Brauner P, Jilkova Z, Stankova B, Tvrzicka E, Bryhn M (2009) n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc Nutr Soc 68(4):361\u2013369","journal-title":"Proc Nutr Soc"},{"key":"506_CR19","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","volume":"25","author":"H Koyama","year":"2005","unstructured":"Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y (2005) Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 25:2587\u20132593","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"506_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.03.025","volume":"234","author":"H Koyama","year":"2014","unstructured":"Koyama H, Tanaka S, Monden M, Shoji T, Morioka T, Fukumoto S, Mori K, Emoto M, Shoji T, Fukui M, Fujii H, Nishizawa Y, Inaba M (2014) Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: randomized controlled trial (PioRAGE). Atherosclerosis 234(2):329\u2013334","journal-title":"Atherosclerosis"},{"key":"506_CR21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/diacare.21.5.717","volume":"21","author":"J Luo","year":"1998","unstructured":"Luo J, Rizkalla SW, Vidal H, Oppert JM, Colas C, Boussairi A, Guerre-Millo M, Chapuis AS, Chevalier A, Durand G, Slama G (1998) Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men: results of a controlled study. Diabetes Care 21:717\u2013724","journal-title":"Diabetes Care"},{"issue":"10","key":"506_CR22","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2337\/diabetes.53.10.2662","volume":"53","author":"N Marx","year":"2004","unstructured":"Marx N, Walcher D, Ivanova N, Ivanova N, Rautzenberg K, Jung A, Friedl R, Hombach V, de Caterina R, Basta G, Wautier MP, Wautiers JL (2004) Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes 53(10):2662\u20132668","journal-title":"Diabetes"},{"key":"506_CR23","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.0510086103","volume":"103","author":"M Massaro","year":"2006","unstructured":"Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler BB, De Caterina R (2006) The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCepsilon inhibition. Proc Natl Acad Sci U S A 103:15184\u201315189","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"506_CR24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pcd.2014.02.004","volume":"8","author":"SM Moosheer","year":"2014","unstructured":"Moosheer SM, Waldsch\u00fctz W, Itariu BK, Brath H, Stulnig TM (2014) A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Prim Care Diabetes 8(4):308\u2013314","journal-title":"Prim Care Diabetes"},{"key":"506_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2337\/diacare.18.1.83","volume":"18","author":"WA Morgan","year":"1995","unstructured":"Morgan WA, Raskin P, Rosenstock J (1995) A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM. Diabetes Care 18:83\u201386","journal-title":"Diabetes Care"},{"issue":"3","key":"506_CR26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jada.2004.11.029","volume":"105","author":"JA Nettleton","year":"2005","unstructured":"Nettleton JA, Katz R (2005) n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105(3):428\u2013440","journal-title":"J Am Diet Assoc"},{"key":"506_CR27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00125-009-1263-5","volume":"52","author":"JW Nin","year":"2009","unstructured":"Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD, EURODIAB Prospective Complications Study Group (2009) Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study. Diabetologia 52:705\u2013714","journal-title":"Diabetologia"},{"issue":"16","key":"506_CR28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.molimm.2003.11.027","volume":"40","author":"IH Park","year":"2004","unstructured":"Park IH, Yeon SI, Youn JH, Choi JE, Sasaki N, Choi IH, Shin JS (2004) Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol 40(16):1203\u20131211","journal-title":"Mol Immunol"},{"key":"506_CR29","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1021\/bi00034a021","volume":"34","author":"S Reddy","year":"1995","unstructured":"Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW (1995) N-epsilon-(carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34:10872\u201310878","journal-title":"Biochemistry"},{"issue":"10","key":"506_CR30","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2337\/db09-1554","volume":"59","author":"A Sato","year":"2010","unstructured":"Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, Mizuguchi K, Itoh M, Suganami T, Ogawa Y (2010) Antiobesity effect of eicosapentaenoic acid in high-fat\/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 59(10):2495\u20132504","journal-title":"Diabetes"},{"key":"506_CR31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI119180","volume":"99","author":"ED Schleicher","year":"1997","unstructured":"Schleicher ED, Wagner E, Nerlich AG (1997) Increased accumulation of the glycoxidation product N-(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457\u2013468","journal-title":"J Clin Invest"},{"key":"506_CR32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0021-9150(97)00298-0","volume":"137","author":"CR Sirtori","year":"1998","unstructured":"Sirtori CR, Crepaldi G, Manzato E, Mancini M, Rivellese A, Paoletti R, Pazzucconi F, Pamparana F, Stragliotto E (1998) One year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis 137:419\u2013427","journal-title":"Atherosclerosis"},{"issue":"7","key":"506_CR33","first-page":"490","volume":"46","author":"A Stirban","year":"2014","unstructured":"Stirban A, Nandrean S, G\u00f6tting C, Stratmann B, Tschoepe D (2014) Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus. Horm Metab Res 46(7):490\u2013492","journal-title":"Horm Metab Res"},{"issue":"9","key":"506_CR34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00125-007-0759-0","volume":"50","author":"KC Tan","year":"2007","unstructured":"Tan KC, Chow WS, Tso AW, Xu A, Tse HF, Hoo RL, Betteridge DJ, Lam KS (2007) Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes. Diabetologia 50(9):1819\u20131825","journal-title":"Diabetologia"},{"issue":"11","key":"506_CR35","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1007\/s00125-006-0394-1","volume":"49","author":"KC Tan","year":"2006","unstructured":"Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ (2006) Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 49(11):2756\u20132762","journal-title":"Diabetologia"},{"issue":"3","key":"506_CR36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/2141-9248.117954","volume":"3","author":"A Udupa","year":"2013","unstructured":"Udupa A, Nahar P, Shah S, Kshirsagar M, Ghongane B (2013) A comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin e in type 2 diabetes mellitus. Ann Med Health Sci Res 3(3):442\u2013446","journal-title":"Ann Med Health Sci Res"},{"issue":"1","key":"506_CR37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/jpet.105.095125","volume":"317","author":"K Wang","year":"2006","unstructured":"Wang K, Zhou Z, Zhang M, Zhang M, Fan L, Forudi F, Zhou X, Qu W, Lincoff AM, Schmidt AM, Topol EJ, Penn MS (2006) Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther 317(1):37\u201343","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"506_CR38","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/ATVBAHA.107.139923","volume":"27","author":"S Yamagishi","year":"2007","unstructured":"Yamagishi S, Imaizumi T (2007) Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes. Arterioscler, Thromb, Vasc Biol 27(6):e32","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"506_CR39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","volume":"370","author":"H Yonekura","year":"2003","unstructured":"Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370:1097\u20131109","journal-title":"Biochem J"},{"key":"506_CR40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.13.2.147","volume":"13","author":"A Zambon","year":"1993","unstructured":"Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD (1993) Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 13:147\u2013153","journal-title":"Arterioscler Thromb"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-016-0506-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13105-016-0506-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-016-0506-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T16:52:49Z","timestamp":1656867169000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13105-016-0506-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,22]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1007\/s13105-016-0506-4","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,22]]}}}